ArticleJournal of gastrointestinal oncology2022

Study on safety and efficacy of regorafenib combined with transcatheter arterial chemoembolization in the treatment of advanced hepatocellular carcinoma after first-line targeted therapy.

Haochen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.